When:
Tuesday, October 18, 2022
11:00 AM - 12:00 PM CT
Where: Robert H Lurie Medical Research Center, Baldwin Auditorium, 303 E. Superior, Chicago, IL 60611 map it
Audience: Faculty/Staff - Student - Post Docs/Docs - Graduate Students
Cost: free
Contact:
Jodi Johnson
Group: Lurie Cancer Center Basic Science Programs
Category: Lectures & Meetings
The Lurie Cancer Center Basic Research Seminar Series presents:
Targeting Clonal Heterogeneity in Treatment-Refractory Glioblastoma with Novel and
Empiric Immunotherapies
Sheila Singh, MD, PhD, FRCS(C)
Professor of Surgery and Biochemistry
Chief Pediatric Neurosurgeon
McMaster Children’s Hospital
Director, Centre for Discovery in Cancer Research
Ontario, Canada
Dr. Singh is currently studying the regulation of brain tumor initiating cell signaling pathways in glioblastoma and brain metastases with the ultimate goal of selectively targeting the brain tumor initiating cells with appropriately tailored drug and molecular therapies. This talk will highlight several methods to target these cells with emphasis on data generated from pre-clinical xenograft mouse models and clinical testing of novel therapeutics for brain tumors.
Hosted by the Lurie Cancer Center's Training Program in Signal Transduction and Cancer (T32 CA070085)
All members of the Northwestern Medicine community are invited to attend.